Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Ondas Inc. Common Stock (ONDS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Ondas Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.3 (market cap $12.58B), while Ondas Inc. Common Stock trades at $6.66 (market cap $3.99B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 3.2× Ondas Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Ondas Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Ondas Inc. Common Stock for 0 Days on average.
| HALO | ONDS | |
|---|---|---|
Market Cap | $12.58B | $3.99B |
Volume | 2,179,278 | 60,542,247 |
Sector | Health | Technology |
52-Week High | $115.22 | $14.01 |
52-Week Low | $61.63 | $5.25 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.49B | $2.62B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Ondas Inc. Common Stock
Ondas provides autonomous systems and private wireless solutions through its Ondas Autonomous Systems, Ondas Capital, and Ondas Networks business units. Its technologies combine aerial intelligence and next-generation connectivity for essential industries.
Read more on ONDS →
